Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Drugs for Preventing Malaria in Pregnant Women in Endemic Areas: Any Drug Regimen versus Placebo or No Treatment

About this resource:

Systematic review

Source: The Cochrane Collaborative

Last Reviewed: October 2014

Workgroups: Global Health Workgroup

In this Cochrane systematic review, the Cochrane Collaborative found that giving women in their 1st or 2nd pregnancy antimalarial drugs can prevent moderate to severe anemia and prevent malaria parasites in the blood. The review included trials that evaluated 6 different antimalarials against placebo or no intervention. Researchers also found that when pregnant women take antimalarial drugs, their babies have increased average birth weight and are less likely to have a low birth weight.

Read more about this resource

Suggested Citation

1.

Radeva‐Petrova, D., Kayentao, K., ter Kuile, F. O., Sinclair, D., & Garner, P. (2014). Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment. Cochrane Database of Systematic Reviews, 2014 (10). DOI: 10.1002/14651858.CD000169.pub3.